FNGAX
Price
$18.57
Change
+$0.08 (+0.43%)
Updated
Jul 3 closing price
Net Assets
894.31M
REEBX
Price
$59.47
Change
+$0.13 (+0.22%)
Updated
Jul 3 closing price
Net Assets
134.48B
Interact to see
Advertisement

FNGAX vs REEBX

Header iconFNGAX vs REEBX Comparison
Open Charts FNGAX vs REEBXBanner chart's image
Franklin Intl Growth A
Price$18.57
Change+$0.08 (+0.43%)
VolumeN/A
Net Assets894.31M
American Funds EUPAC R2E
Price$59.47
Change+$0.13 (+0.22%)
VolumeN/A
Net Assets134.48B
FNGAX vs REEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNGAX vs. REEBX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNGAX is a StrongBuy and REEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REEBX has more cash in the bank: 134B vs. FNGAX (894M). FNGAX pays higher dividends than REEBX: FNGAX (1.70) vs REEBX (0.42). FNGAX was incepted earlier than REEBX: FNGAX (17 years) vs REEBX (11 years). REEBX (1.27) is less costly to investors than FNGAX (1.20). REEBX is a more actively managed with annual turnover of: 30.00 vs. FNGAX (17.56). REEBX has a lower initial minimum investment than FNGAX: REEBX (250) vs FNGAX (1000). FNGAX annual gain was more profitable for investors over the last year : 10.35 vs. REEBX (4.69). REEBX return over 5 years is better than : 14.67 vs. FNGAX (6.62).
FNGAXREEBXFNGAX / REEBX
Total Expense Ratio1.121.2788%
Annual Report Gross Expense Ratio1.201.2794%
Fund Existence17 years11 years-
Gain YTD14.96612.739117%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets894M134B1%
Annual Yield % from dividends1.700.42404%
Returns for 1 year10.354.69221%
Returns for 3 years32.8928.27116%
Returns for 5 years6.6214.6745%
Returns for 10 years73.0423.99304%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRDF3.660.07
+1.95%
Cardiff Oncology
HOMB29.810.29
+0.98%
Home BancShares
HY42.540.27
+0.64%
Hyster-Yale Inc.
LICN4.18N/A
N/A
Lichen International Limited
NTES132.85-0.15
-0.11%
NetEase